Searched for
BRITISH DRUGS FIRM
Blackstone, CD&R explore bids for Ben & Jerry's owner MagnumPrivate equity firms Blackstone and CD&R are exploring bids for Magnum Ice Cream Company. Magnum was recently spun out of Unilever. The fir...- Is Lorna Hajdini married? What we know about JP Morgan executive's love life amid row over Chirayu Rana’s bombshell sexual harassment allegations against herJ.P. Morgan executive Lorna Hajdini faces sexual harassment allegations from former employee Chirayu Rana, who claims he was drugged and co...
- Who is Chirayu Rana? Ex-JPMorgan staffer makes shocking sexual-harassment claims on company’s high-ranking executive Lorna HajdiniA former JPMorgan employee, Chirayu Rana, 35 , is accused of fabricating sexual harassment claims against executive Lorna Hajdini. An inter...
- OpenAI launches AI model GPT-Rosalind for life sciences researchThe GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug ...
- Demand for senior technology leaders in India is bucking a slowdown in broader tech hiringAs per experts, many MNCs are considering shifting global tech positions to India, mostly to their GCCs. Ratna Gupta, senior partner, ABC C...
- UK to offer to pay more for some drugs to appease Trump: ReportThe British government will offer to pay more for medicines bought by the NHS, aiming to defuse U.S. President Donald Trump's complaints ab...
- Global companies account for 60% of Indian vaccine sales by valueIndia's vaccine market is steadily recovering after the impact from Covid-19 and multinationals are back to slowly gaining traction, sugges...
- Legacy pharma firm which sold 'Swadeshi' dysentery drug to Afghans waits and watches after Taliban takeoverThe company, which started out in a small garage on Hare Street, was set up as a 'Swadeshi enterprise' meant to take on the stranglehold of...
- Kochi firm PNB Vesper Life Sciences completes phase 2 clinical trial of coronavirus drugThe company on Monday said the clinical trial was initiated in November at BJ Government Medical College and Sassoon General Hospital in Pu...
- AstraZeneca shares sink 8% after $39 billion Alexion buyoutChief Executive Officer Pascal Soriot had told reporters on Saturday that the deal, a bet on rare-disease and immunology drugs, was the res...
- British drug maker AstraZeneca may launch innovative drugs in IndiaBritish drug maker AstraZeneca is betting big on Asia including emerging markets such as India where it plans to introduce innovative produ...
- AstraZeneca leaves door ajar to Pfizer, despite hurdlesAstraZeneca's boss said he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's ops int...
- Wockhardt revenues may dip up to $250 m on USFDA banWockhardt may suffer an annual revenue fall of up to $250 million and its American operations may grind to a halt.
- American firm Abbott consolidates top position in Indian drug marketAmerican firm Abbott Laboratories consolidated its top position in the Indian drug retail market by growing at a faster than its closest co...
- GlaxoSmithKline reports quarterly lossBritish drugs firm GlaxoSmithKline on Thursday posted a net loss of £690 mn (813 mn euros, $1.119 bn) for the fourth quarter of 2010 on the...
- Glaxo in talks to buy India's Piramal Healthcare: Media reportBritish pharma major GlaxoSmithKline Plc is in discussions to acquire Indian generic drug maker Piramal Healthcare for nearly $1.5 billion,...
- Alkem recalls three lakh injections from abroadAlkem alleges that Synergia and Centre Specialities Export Pharma were trying to malign the company after it decided to tap France & Africa...
- UK gets tough on pharma cos' clinical trialsBritain plans to force pharmaceutical companies to share more information with regulators about clinical trials after an investigation rece...
- Dr Reddy's enters into agreement with UK firmPharmaceutical major Dr Reddy's Laboratories today said it has entered into an agreement with British company SkyePharma Plc to undertake a...
- GSK to offer $15 bn for Pfizer unit: reportThe British-based pharmaceutical group GlaxoSmithKline (GSK) is planning to offer more than $15 billion dollars for the consumer health car...
Load More
